Literature DB >> 121114

Serospecificity and opsonic activity of antisera to Legionella pneumophila.

W Johnson, E Pesanti, J Elliott.   

Abstract

A high-molecular-weight surface component (F-1 fraction) has been isolated from the four serogroups of Legionella pneumophila. Antibody raised against live organisms was found by microagglutination assay to be specific for the homologous serogroup. Agglutinating activity of antiserum was markedly diminished after absorption with the homologous, but not heterologous, F-1 fraction. In addition, it was found that L. pneumophila organisms were not interiorized by rat alveolar macrophages or mouse peritoneal macrophages in the absence of antiserum, whereas homologous antiserum effectively opsonized the organisms. The opsonizing activity of serogroup-specific antisera was eliminated by absorption of the antisera with the homologous, but not heterologous, F-1 fraction. These data indicate that the serogroup-specific antigen of L. pneumophila resides in the F-1 fraction and that antibody to the F-1 fraction is required for phagocytosis of L. pneumophila by mammalian phagocytes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 121114      PMCID: PMC414672          DOI: 10.1128/iai.26.2.698-704.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Primary isolation media for Legionnaires disease bacterium.

Authors:  J C Feeley; G W Gorman; R E Weaver; D C Mackel; H W Smith
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

3.  Two-hour embedding procedure for intracellular detection of viruses by electron microscopy.

Authors:  F W Doane; N Anderson; J Chao; A Noonan
Journal:  Appl Microbiol       Date:  1974-02

4.  Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium.

Authors:  R J Arko; K H Wong; J C Feeley
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

5.  Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests.

Authors:  C E Farshy; G C Klein; J C Feeley
Journal:  J Clin Microbiol       Date:  1978-04       Impact factor: 5.948

6.  Legionnaires' disease: antigenic peculiarities, strain differences, and antibiotic sensitivities of the agent.

Authors:  R A Ormsbee; M G Peacock; G L Lattimer; L A Page; P Fiset
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226

7.  Legionnaires' disease. Pathological and historical aspects of a 'new' disease.

Authors:  J A Blackmon; M D Hicklin; F W Chandler
Journal:  Arch Pathol Lab Med       Date:  1978-07       Impact factor: 5.534

8.  Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease.

Authors:  J E McDade; C C Shepard; D W Fraser; T R Tsai; M A Redus; W R Dowdle
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

9.  A high molecular weight antigen in Legionnaires' disease bacterium: isolation and partial characterization.

Authors:  W Johnson; J A Elliott; C M Helms; E D Renner
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

10.  Classification of the Legionnaires' disease bacterium: Legionella pneumophila, genus novum, species nova, of the family Legionellaceae, familia nova.

Authors:  D J Brenner; A G Steigerwalt; J E McDade
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

View more
  15 in total

1.  Treatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila.

Authors:  J A Elliott; W C Winn
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

2.  Cytotoxicity of extracellular Legionella pneumophila.

Authors:  L K Husmann; W Johnson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

3.  Factors influencing the reactivity of Legionella antigens in immunofluorescence tests.

Authors:  R F Benson; G B Malcolm; L Pine; W K Harrell
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

4.  Production of monoclonal antibodies to Legionella pneumophila serogroups 1 and 6.

Authors:  M F Para; J F Plouffe
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

5.  Immunological and biochemical relationships among flagella isolated from Legionella pneumophila serogroups 1, 2, and 3.

Authors:  J A Elliott; W Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

6.  Ultrastructural localization and protective activity of a high-molecular-weight antigen isolated from Legionella pneumophila.

Authors:  J A Elliott; W Johnson; C M Helms
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

7.  Interaction of primate alveolar macrophages and Legionella pneumophila.

Authors:  R F Jacobs; R M Locksley; C B Wilson; J E Haas; S J Klebanoff
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

8.  Relative potency of virulent versus avirulent Legionella pneumophila for induction of cell-mediated immunity.

Authors:  T W Klein; H Friedman; R Widen
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

9.  Characteristics of anti-Legionella antibodies in patients infected with Legionella pneumophila serogroups 1, 6, and 10.

Authors:  T L van Zwet; P L Meenhorst; P C Leijh; M R Daha; R van Furth
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

10.  Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila.

Authors:  J G Guillet; J Hoebeke; C Tram; S Marullo; A D Strosberg
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.